The centrosome acts as the microtubule-organizing center (MTOC) during mitosis in animal cells. Microtubules are nucleated and anchored by g-tubulin ring complexes (g-TuRCs) embedded within the centrosome's pericentriolar material (PCM). The PCM is required for the localization of g-TuRCs, and both are steadily recruited to the centrosome, culminating in a peak in MTOC function in metaphase [1] . In differentiated cells, the centrosome is often attenuated as an MTOC and MTOC function is reassigned to noncentrosomal sites such as the apical membrane in epithelial cells, the nuclear envelope in skeletal muscle, and down the lengths of axons and dendrites in neurons [2] [3] [4] [5] [6] . Hyperactive MTOC function at the centrosome is associated with epithelial cancers and with invasive behavior in tumor cells [7] [8] [9] [10] [11] . Little is known about the mechanisms that limit MTOC activation at the centrosome. Here, we find that MTOC function at the centrosome is completely inactivated during cell differentiation in C. elegans embryonic intestinal cells and MTOC function is reassigned to the apical membrane. In cells that divide after differentiation, the cellular MTOC state switches between the membrane and the centrosome. Using cell fusion experiments in live embryos, we find that the centrosome MTOC state is dominant and that the inactive MTOC state of the centrosome is malleable; fusion of a mitotic cell to a differentiated or interphase cell results in rapid reactivation of the centrosome MTOC. We show that conversion of MTOC state involves the conserved centrosome protein SPD-2/CEP192 and CDK activity from the mitotic cell.
RESULTS

The Apical Surface of Polarized Embryonic Intestinal Cells Is an MTOC
The C. elegans intestine is a simple tube comprised of 20 epithelial cells polarized toward a central lumen ( Figure S1 ). Embryonic intestinal cells polarize at the 16 intestinal cell stage (4.5 hr into development). Cell polarization involves a 90-degree reorientation of the centrosome from the lateral membrane to the future apical surface [2, 12] . During the cell divisions within the intestinal primordium, the centrosome serves as the microtubuleorganizing center (MTOC), localizing g-tubulin ring complexes (g-TuRC) proteins such as GIP-1/Spc98p/GCP3 and microtubules ( Figure 1A ). During polarization, MTOC function becomes reassigned to the apical surface ( Figures 1B and 1D ) [2] . We previously showed that, in polarized wild-type intestines, centrosomes localize in close proximity to the apical membrane [2, 12] . To create more physical distance between the centrosomes and the apical surface for imaging purposes, we used a mutant in the SUN/KASH domain protein UNC-83, in which nuclei and the attached centrosomes are not retained at the apical surface [13] . In unc-83 mutants, like in wild-type, GIP-1 and microtubules localize to apical membranes [2] (Figure 1B ). Electron microscopy further revealed the association of microtubules with electron dense material at the apical membrane ( Figure 1C ). To determine whether microtubules are nucleated from the apical surface, we eliminated microtubules by treating embryos with the microtubule-depolymerizing drug nocodazole ( Figure 1E ). Following nocodazole washout, microtubules regrow from the apical surface, rather than from the centrosomes ( Figure 1F ). Together, these data indicate that the apical surface of intestinal cells becomes an MTOC during polarization and that the centrosome is inactivated as an MTOC. Intriguingly, a recent report found that intestinal centrosomes are eliminated during larval stages, suggesting that centrosomes are dispensable once they are no longer needed for mitosis [14] .
Microtubule organization can dramatically change in polarized tissue culture cells that re-enter the cell cycle [15] . We wanted to determine what happens to the MTOC state of differentiated cells undergoing additional divisions within the embryo. Four intestinal cells divide one additional time after differentiation to go from the 16-cell polarized intestinal primordium to the 20 cells that constitute the adult intestine ( Figure S1 ). Using g-tubulin (TBG-1) as a proxy for MTOC activity, we found that cells appear to switch between MTOC states. In polarized cells, GFP:gtubulin is localized to the apical membrane ( Figure 1G ; Movie S1). During division, the centrosomes enlarge and accumulate GFP:g-tubulin. Concomitantly, GFP:g-tubulin is lost from the apical membranes of the dividing cells. Following division, GFP:g-tubulin returns to the apical membrane and becomes severely reduced at the centrosomes. These data indicate that intestinal cells cycle between MTOC states but do not maintain both states. Microtubules were removed by treatment with nocodazole (E). After wash out of nocodazole from the media, microtubules regrow from apical membranes rather than from centrosomes (F; green). (G) Images from a live recording of the E16-E20 division in the intestinal primordium depicting a switch in MTOC state. Polarized cells have membrane-localized GFP:g-tubulin (TBG-1), but GFP:g-tubulin at the centrosomes is barely visible (joined white arrows). During division, centrosomes localize large amounts of GFP:g-tubulin (joined white arrows) and GFP:g-tubulin disappears from the membrane. Following division, GFP:g-tubulin returns to the membrane. (H) Cells from a cycling embryo expressing GFP:g-tubulin (GFP:TBG-1); Cherry:a-tubulin (Cherry:TBA-1). The levels of GFP:g-tubulin and Cherry:a-tubulin appear to cycle at the centrosome and are correlated. In interphase, little if any Cherry:a-tubulin co-localizes with the centrosome. The scale bar represents 200 nm in (C) and 2.5 mm in all other panels. See also Figure S1 and Movie S1.
The Centrosome MTOC State Is Dominant
The ability of cells to switch between MTOC states raises the question of how cells normally ''choose'' their MTOC state. Why are centrosomes in differentiated intestinal cells able to remain inactive, despite the abundance of microtubules and microtubule-nucleating proteins at the nearby apical surface? To address this question, we turned to cell fusion experiments. Cell fusion has provided insight into a number of questions related to state dependence [16] [17] [18] . Previous cell fusion experiments relied on lengthy cell fusion procedures involving chemical-or viral-induced fusion. In contrast, C. elegans cells can be readily and instantaneously fused with a laser [19] . Thus, we can fuse a dividing intestinal cell with its differentiated neighbor. The outcome of this experiment can inform the mechanism of how a cell chooses its MTOC state. If the centrosome or membrane MTOC state is dominant, then fusion of the mitotic and polarized cell will result in the conversion of either cell to the dominant state ( Figure 2A ). Alternatively, if the cell arrives at its MTOC state through two independent pathways, then cell fusion would result in both MTOC states co-existing in the same cytoplasm ( Figure 2A ).
Prior to cell fusion, the mitotic cell had large centrosomes with an abundance of GFP:g-tubulin and had lost GFP:g-tubulin from the membrane ( Figures 1G and 2B ). The adjacent differentiated cell had membrane-localized GFP:g-tubulin and small centrosomes localizing little GFP:g-tubulin ( Figures 1G and 2B ). After laser fusion, the membrane between the two cells disappeared, but the rest of the cell appeared unaffected ( Figure 2C ). Within 4 min after fusion, the centrosomes in the differentiated cell accumulated GFP:g-tubulin and GFP:g-tubulin disappeared from the apical membrane ( Figure 2D ; n = 6). We refer to this state as ''fusion conversion.'' In all cases, cell fusion also led to an increased separation of the two centrosomes (compare Figures 2C and 2D) . Interestingly, during the timescale of fusion TBG-1 conversion of MTOC state, we did not see chromosome condensation or nuclear envelope breakdown in the differentiated cell following fusion. These data have three implications: (1) the MTOC state of a centrosome in a differentiated cell is readily malleable, suggesting that MTOC inactivation is not normally achieved through an irreversible change to the centrosome; (2) the centrosome MTOC state is dominant; mitotic cytoplasm can convert the inactive centrosome to an MTOC and can remove the membrane MTOC; and (3) mitotic cytoplasm can convert the MTOC state of the differentiated cell without immediately inducing hallmarks of mitosis such as chromosome condensation or nuclear envelope breakdown.
Within the invariant C. elegans lineage, there are instances when a mitotic cell is adjacent to a cell in interphase, a state in which the centrosome appears to be inactivated as an MTOC [20] (Figure 1H ). We performed cell fusion between a mitotic cell and an interphase cell in cycling embryos to determine whether fusion conversion is common to different types of cells with centrosomes that are inactive as MTOCs. In the earliest divisions, cells rapidly cycle between S and M phase without intervening gap phases. After the third round of divisions, the cell cycles begin to slow, and the first true gap phases occur in the fourth round of divisions in Ea and Ep cells [21] . We therefore limited our analysis to embryos at this stage or older. As with fusion of intestinal cells, we saw that the centrosome MTOC state was dominant in cycling cells. Fusion of a mitotic cell to an interphase cell resulted in the enlargement and separation of the interphase centrosomes within 3 min ( Figures  2E-2G ). This increase in centrosome size and GFP:g-tubulin localization was also accompanied by an increase in microtubule association (Figures 2H-2J ) and accumulation of the core pericentriolar material (PCM) proteins SPD-2/CEP192 and SPD-5 ( Figure S2 ).
Fusion Conversion of the Interphase Cell Uses SPD-2 from the Mitotic Cell
The speed of fusion conversion of MTOC state suggests that a factor provided by mitotic cytoplasm is able to convert the MTOC state of either a differentiated or an interphase cell. To test this hypothesis, we determined the source of candidate proteins adding onto the centrosome following fusion conversion. We photobleached all of the GFP-tagged candidate protein in the mitotic cell prior to fusion and measured the ''fold change'' in GFP fluorescence at the centrosome before and after fusion with and without bleaching prior to fusion ( Figure 3A) . The fold change of proteins adding onto the interphase centrosome that come from the interphase cell should be unaffected by bleaching. In contrast, proteins that add onto the interphase centrosome that come only from the mitotic cell should have significantly reduced fold change after mitotic cell bleaching.
MTOC assembly at the centrosome in C. elegans involves a relatively simple network of proteins. SPD-2/CEP192 and SPD-5 are core PCM proteins required for the localization of most centrosome components [22] [23] [24] . Together, these proteins localize additional factors such as g-TuRC proteins that allow for microtubule nucleation and organization (for review, see [25] ). We took a candidate approach and tested the source of GFP:g-tubulin, GFP:SPD-5, and GFP:SPD-2 adding onto the interphase centrosome following fusion conversion ( Figures  3B-3K ). The accumulation of GFP:g-tubulin at the interphase centrosome was unaffected by mitotic cell bleaching ( Figures  3B and 3C-3E ; fold-change fusion : 6.7 ± 2.0, n = 5; foldchange bleach(m) + fusion : 7.3 ± 2.6, n = 8; t test; p = 0.64). Similarly, GFP:SPD-5 localization to the interphase centrosome was unaffected by bleaching the mitotic cell prior to fusion ( Figures  3B and 3F-3H ; fold-change fusion : 7.8 ± 3.6, n = 5; foldchange bleach(m) + fusion : 7.0 ± 4.0, n = 6; t test; p = 0.73). In contrast, bleaching mitotic cytoplasm prior to fusion significantly decreased GFP:SPD-2 localization to the interphase centrosome compared to fusion without bleaching ( Figures 3B and 3I-3K ; fold-change fusion : 3.8 ± 1.8, n = 5; fold-change bleach(m) + fusion :
1.3 ± 0.6, n = 5; t test; p < 0.03). In all cases, GFP fluorescence recovered at the centrosomes in the mitotic cell, although to a significantly lesser extent than before bleaching (mean recovery = 16.3% [GFP:SPD-2; n = 5], 24.8% [GFP:TBG-1; n = 8], and 24.6% [GFP:SPD-5; n = 6]). Interestingly, we often saw GFP:SPD-2 first recover closest to the centriole ( Figure 3K ), consistent with previous reports that some PCM proteins have an inside-out accumulation pattern [23, 26] . These data suggest that SPD-2 adding onto the interphase centrosome following fusion conversion comes only from the mitotic cell. As a further test of this model, we bleached all of the GFP:SPD-2 in the interphase cell prior to cell fusion. In contrast to what we observed for bleaching GFP:SPD-2 in the mitotic cell, we saw that bleaching the interphase GFP:SPD-2 prior to cell fusion had no significant impact on the accumulation of GFP:SPD-2 at the interphase centrosomes (Figures S2I-S2K ; fold-change fusion : 3.8 ± 1.8, n = 5; fold-change bleach(i) + fusion : 4.0 ± 2.8, n = 5; t test; p = 0.92). These results suggest that SPD-2 is limiting in the interphase cell for MTOC activation. All of the GFP constructs tested were maternally expressed, such that the amount of GFP:SPD-2 was not significantly different between interphase and mitotic cells (see Experimental Procedures). Thus, this limitation cannot simply be due to a lack of SPD-2 in interphase cytoplasm. Consistent with this observation, forced expression of SPD-2 in differentiated intestinal cells did not lead to a reactivation of the centrosome as an MTOC (Figure S3) . Together, these results suggest that, in an interphase cell, the centrosome is inactive as an MTOC due to a lack of active SPD-2. Moreover, the observation that SPD-2 adding onto the interphase centrosome after cell fusion comes only from the mitotic cell implies that the pool of SPD-2 in the interphase cell cannot itself be immediately activated by mitotic cytoplasm.
Cell-Cycle-Dependent Regulation of Fusion Conversion
We tested whether fusion conversion was dependent on cell-cycle state. Mitotic cytoplasm from a cell in prophase or metaphase has the ability to convert MTOC state of an interphase or differentiated cell (Figures 2 and S3 ). In contrast, mitotic cytoplasm from a cell in anaphase or telophase is incapable of converting MTOC state ( Figures 4A, 4B , and S4). These results suggest that cell-cycle-dependent kinase (CDK) activity might be required for fusion conversion. To test this hypothesis, we treated embryos with the CDK inhibitor flavopiridol [27] . Normally, PCM size should steadily increase as cells progress toward metaphase ( Figure 1H ). In contrast, treatment of prophase to metaphase stage cells with flavopiridol resulted in a steady decrease in GFP:g-tubulin localization at the centrosome ( Figure 4C ; n = 48). To test whether CDK activity was required for fusion conversion, we pre-treated embryos for 2 min with flavopiridol, fused a mitotic cell and an interphase cell, and then imaged with 3-min time steps. Treatment with flavopiridol inhibited fusion conversion of MTOC state in the interphase cell, despite the fact that the mitotic centrosomes still retained PCM ( Figures 4D and 4E) . Together, these results suggest that cells require CDK for the maintenance and activation of MTOC function at the centrosome.
DISCUSSION
The choice of MTOC state is a decision faced by the cell every cell cycle. Here, using a novel cell-fusion assay in live embryos, we found that the pathways for obtaining different MTOC states are linked, with the centrosome MTOC state being dominant. We found that the MTOC state of a differentiated or interphase cell could be rapidly converted to the mitotic centrosome MTOC state. This conversion appeared to occur without accompanying chromosome condensation, suggesting that conversion of MTOC state results from the diffusion of specific factors from the mitotic cell rather than from the immediate induction of a mitotic program in the interphase cell. The rapid cell cycles in the developing embryo did not allow us to test whether increased incubation would result in mitotic events such as chromosome condensation or nuclear envelope breakdown that is predicted from classic cell fusion experiments [18] . Interestingly, a previous report found that the nuclear MTOC state of a muscle cell can convert the centrosome MTOC state of a U2OS cell, suggesting that, in some contexts, a non-centrosomal MTOC state can be dominant [28] . By combining photobleaching with cell fusion, we found that the SPD-2 adding onto the centrosome in the interphase cell following fusion conversion came only from the mitotic cell. Somewhat paradoxically, SPD-2 is associated with the centriole during interphase and overexpression of SPD-2 in intestinal cells did not lead to spurious activation of the centrosome as an MTOC (Figures 3 and  S4) . Previous imaging studies position SPD-2 at the interface between the centriole and the PCM, with a population of SPD-2 at the centriole cylinder and another population within the PCM matrix itself [23, 29, 30] . Together with our observations, these results suggest that SPD-2 in any state can interact with the centriole but that an active form might serve as the linchpin that hooks PCM proteins to the centriole barrel. A similar function had previously been proposed for PLP and Cnn in Drosophila; however, neither of these proteins have clear homologs in C. elegans [29, 31] . Our findings are consistent with a recent report showing that, in Drosophila, SPD-2 works together with Cnn to recruit mitotic PCM to the mother centriole [32] . The total amount of SPD-2 in the cell had previously been suggested to limit PCM size in mitotic cells [33] . Our data suggest that activation of MTOC function at the centrosome requires an active pool of SPD-2. We speculate that the limitation of SPD-2 on PCM size might also be dictated by the amount of active SPD-2 rather than by the total amount of SPD-2 within the cell.
Our data from experiments in cycling cells suggest a model where the centrosome is inactive as an MTOC in differentiated or interphase cells due to an inactive form of SPD-2 ( Figure 4F) ; upon entry into mitosis, SPD-2 becomes activated either indirectly or directly through regulation by CDK, which allows for activation of MTOC activity through the recruitment of additional factors such as SPD-5, g-tubulin, and additional SPD-2. The implication that CDK from the mitotic cell does not activate SPD-2 in the interphase cell suggests that SPD-2 is activated exclusively at the mitotic centrosome. Recent biochemical studies point to a SPD-2/CEP192 organized cascade that is required for centrosome maturation [34] . This cascade involves the recruitment of Aurora A and Plk1 by SPD-2/CEP192, which allows for the recruitment of additional PCM components, including g-tubulin. Thus, CDK might be acting indirectly in this process through the activation of PLK or Aurora A or directly on SPD-2. As hyperactive MTOC function at the centrosome has been reported in several types of epithelial cancers and is a hallmark of breast tumors, the ability to specifically attenuate MTOC activity at the centrosome could be an important therapeutic avenue to attack mitotic microtubules without affecting non-centrosomal microtubules in differentiated cells [7, 35] . 
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